Zobrazeno 1 - 10
of 125
pro vyhledávání: '"human disease animal model"'
Autor:
Li, Huiping1 (AUTHOR) lihp_666@gdlami.com, Zhang, Wenjuan2 (AUTHOR)
Publikováno v:
PLoS ONE. 2/9/2023, Vol. 17 Issue 2, p1-20. 20p.
Autor:
Huiping Li, Wenjuan Zhang
Publikováno v:
PLoS ONE, Vol 18, Iss 2, p e0281383 (2023)
BackgroundCurrently there is no unified data classification and coding standard for the existing human disease animal model resource data worldwide. Different data classification and coding systems produce different retrieval methods. Some of these m
Externí odkaz:
https://doaj.org/article/1d2833078fbd426da40d5153734c6971
Autor:
Huiping Li, Wenjuan Zhang
Publikováno v:
SSRN Electronic Journal.
Autor:
Keishi Kisoh, Go Sugahara, Yuko Ogawa, Suzue Furukawa, Yuji Ishida, Takeshi Okanoue, Michinori Kohara, Chise Tateno
Publikováno v:
Biomedicines, Vol 9, Iss 11, p 1647 (2021)
Nonalcoholic fatty liver disease/steatohepatitis (NAFLD/NASH) is the most common liver disorder in developed countries. Although many new therapeutics for NASH are present in the drug development pipeline, there are still no approved drugs. One of th
Externí odkaz:
https://doaj.org/article/65006a448cac4620b052520da4f8a0a4
Autor:
Suzue Furukawa, Michinori Kohara, Go Sugahara, Yuji Ishida, Yuko Ogawa, Chise Tateno, Takeshi Okanoue, Keishi Kisoh
Publikováno v:
Biomedicines, Vol 9, Iss 1647, p 1647 (2021)
Biomedicines
Biomedicines; Volume 9; Issue 11; Pages: 1647
Biomedicines
Biomedicines; Volume 9; Issue 11; Pages: 1647
Nonalcoholic fatty liver disease/steatohepatitis (NAFLD/NASH) is the most common liver disorder in developed countries. Although many new therapeutics for NASH are present in the drug development pipeline, there are still no approved drugs. One of th
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
International Journal of Nanomedicine, Vol Volume 19, Pp 9227-9253 (2024)
Guoqiang Xu,1,2,* Xiaona Song,2,* Xiaotang Wang,1,2,* Rui Xue,1,2 Xiaoru Yan,1,2 Litao Qin,1,2 Xiaoqi Chang,1,2 Jiping Gao,1 Zhaoyang Chen,1 Guohua Song1 1Laboratory Animal Center Shanxi Key Laboratory of Experimental Animal Science and H
Externí odkaz:
https://doaj.org/article/8e03627a33cc4ffb8aa300eb947ad717
Autor:
Iacono, Diego1,2,3,4,5,6 (AUTHOR) diego.iacono.ctr@usuhs.edu, Hatch, Kathleen1,3,5 (AUTHOR), Murphy, Erin K.1,3,5 (AUTHOR), Post, Jeremy7 (AUTHOR), Cole, Robert N.7 (AUTHOR), Perl, Daniel P.1,3 (AUTHOR), Day, Regina M.8 (AUTHOR)
Publikováno v:
PLoS ONE. 3/1/2024, Vol. 19 Issue 2, p1-18. 18p.
Autor:
Ruijing Tang, Luobin Guo, Tingyu Wei, Tingting Chen, Huan Yang, Honghao Ye, Fangzhou Lin, Yongyi Zeng, Haijun Yu, Zhixiong Cai, Xiaolong Liu
Publikováno v:
eLife; 9/13/2024, p1-22, 22p
Autor:
Qiu, Liman, Ji, Hongbing, Wang, Kai, Liu, Wenhan, Huang, Qizhen, Pan, Xinting, Ye, Honghao, Li, Zhenli, Chen, Geng, Xing, Xiaohua, Dong, Xiuqing, Tang, Ruijing, Xu, Haipo, Liu, Jingfeng, Cai, Zhixiong, Liu, Xiaolong
Publikováno v:
EMBO Molecular Medicine; May2024, Vol. 16 Issue 5, p1193-1219, 27p